Clinical aspects of vascular remodeling

Journal of Cardiovascular Electrophysiology

Volumn 10, Issue 7, 1999, Pages 1016-1024

  Herity, Niall A ^a   Ward, Michael R ^a   Lo, Sidney ^a   Yeung, Alan C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aneurysm; Angioplasty; Atherosclerosis; Restenosis; Transplant coronary artery disease; Vascular remodeling

Indexed keywords

ANEURYSM; ANGIOPLASTY; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESTENOSIS; REVIEW; ANIMAL; CORONARY ARTERY ATHEROSCLEROSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

CELL ADHESION MOLECULE; GROWTH PROMOTOR; PROTEINASE;

ANIMALS; BLOOD FLOW VELOCITY; CELL ADHESION MOLECULES; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; GROWTH SUBSTANCES; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0033160719     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1999.tb01273.x     Document Type: Review

References (73)

1. 1. Glagov S, Weisenberg E, Zarins CK, et al: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375.
2. 2. Dickey RP, Hower JF: Ultrasonographic features of uterine blood flow during the first 16 weeks of pregnancy. Hum Reprod 1995;10:2448-2552.
3. 3. Pfeffer MA: Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 1995;46:455-466.
4. 4. Tieleman RG, Van Gelder IC, Crijns HJ, et al: Early recurrences of atrial fibrillation after electrical cardio-version: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-173.
5. 5. Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22(Suppl 4):S1-14.
6. 6. Cowan DB, Langille BL: Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol 1996;7:94-100.
7. 7. Cooke JP, Dzau VJ: Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation 1997;96:379-382.
8. 8. Cheng GC, Briggs WH, Gerson DS, et al; Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ Res 1997;80:28-36.
9. 9. Lee RT, Schoen FJ, Loree HM, et al: Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol 1996;16:1070-1073.
10. 10. Cowan DB, Lye SJ, Langille BL: Regulation of vascular connexin43 gene expression by mechanical loads. Circ Res 1998;82:786-793.
11. 11. Nicotera P, Orrenius S: The role of calcium in apoptosis. Cell Calcium 1998;23:173-180.
12. 12. Mondy JS, Lindner V, Miyashiro JK, et al: Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. Circ Res 1997;81:320-327.
13. 13. Ward MR, Agrotis A, Jennings GLR, et al: Flow affects neointima formation and vessel remodelling after experimental angioplasty by inhibition of cell migration and migratory protein mRNA expression. (Abstract) Circulation 1997;96:I-548.
14. 14. de Kleijn DP, van der Zandern J, Schoneveld AH, et al: Matrix metalloproteases 2 and 9 are differentially regulated during flow induced remodeling of rabbit femoral and carotid arteries. (Abstract) Circulation 1997;96:I-172.
15. 15. Bassiouny HS, Song RH, Hong XF, et al: Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Circulation 1998;98:157-163.
16. 16. Abbruzzese TA, Guzman RJ, Martin RL, et al: Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model. Surgery 1998;124:328-334.
17. 17. Pasterkamp G, Borst C, Post MJ, et al: Atherosclerotic arterial remodeling in the superficial femoral artery. Individual variation in local compensatory enlargement response. Circulation 1996:93:1818-1825.
18. 18. Berglund H, Luo H, Nishioka T, et al: Highly localized arterial remodeling in patients with coronary atherosclerosis: An intravascular ultrasound study. Circulation 1997;96:1470-1476.
19. 19. Zeiher AM, Drexler H, Wollschlager H, et al: Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
20. 20. Tagawa H, Tomoike H, Nakamura M: Putative mechanisms of the impairment of endothelium-dependent relaxation of the aorta with atheromatous plaque in heritable hyperlipidemic rabbits. Circ Res 1991;68:330-337.
21. 21. Mintz GS, Kent KM, Pichard AD, et al: Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation 1997;95:1791-1798.
22. 22. Pasterkamp G, Schoneveld AH, van Wolferen W, et al: The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study. Arterioscler Thromb Vasc Biol 1997;17:3057-3063.
23. 23. Tauth J, Pinnow E, Sullebarger JT, et al: Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. Am J Cardiol 1997;80:1352-1355.
24. 24. Weissman NJ, Chari R, Mendelsohn FO, et al: Patient and plaque characteristics associated with coronary artery remodelling: An intravascular ultrasound analysis. (Abstract) J Am Coll Cardiol 1997;29:124A.
25. 25. de Smet BJ, Pasterkamp G, van der Helm YJ, et al: The relation between de novo atherosclerosis remodeling and angioplasty-induced remodeling in an atherosclerotic Yucatan micropig model. Arterioscler Thromb Vasc Biol 1998;18:702-707.
26. 26. Ozaki Y, Violaris A, de Feyter P, et al: Impact of de novo vascular remodelling mode on the mechanisms of acute luminal gain and late restenosis following coronary balloon angioplasty and directional coronary atherectomy: A serial intracoronary ultrasound study. (Abstract) Eur Heart J 1996;18:283.
27. 27. Holvoct P, Theilmeier G, Shivalkar B, et al: LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs. Arterioscler Thromb Vasc Biol 1998;18:415-422.
28. 28. Wong LC, Langille BL: Developmental remodeling of the internal elastic lamina of rabbit arteries: Effect of blood flow. Circ Res 1996;78:799-805.
29. 29. Kwon HM, Sangiorgi G, Spagnoli LG, et al: Experimental hypercholesterolemia induces ultrastructural changes in the internal elastic lamina of porcine coronary arteries. Atherosclerosis 1998;139:283-289.
30. 30. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: A potential mechanism of lesion stabilization. Circulation 1998;97:2433-2444.
31. 31. Kearney P, Erbel R, Rupprecht HJ, et al: Differences in the morphology of unstable and stable coronary lesions and their impact on the mechanisms of angioplasty. An in vivo study with intravascular ultrasound. Eur Heart J 1996;17:721-730.
32. 32. Schwarzacher S, Huegel H, Fitzgerald P, et al: Ruptured plaques have greater degree of remodelling than stable lesions: An IVUS study. (Abstract) Eur Heart J 1998;19:588.
33. 33. Nishioka T, Luo H, Nagai T, et al: Impact of coronary artery remodeling on clinical manifestations of patients with de novo coronary artery lesions. (Abstract) J Am Coll Cardiol 1997;29:125A.
34. 34. Brown DL, Hibbs MS, Kearney M, et al: Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995;91:2125-2131.
35. 35. Libby P, Geng YJ, Aikawa M, et al: Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996;7:330-335.
36. 36. Gallo P, Agozzino L, Angelini A, et al: Causes of late failure after heart transplantation: A ten-year survey. J Heart Lung Transplant 1997;16:1113-1121.
37. 37. Billingham ME: The pathologic changes in long-term heart and lung transplant survivors. J Heart Lung Transplant 1992;11:S252-S257.
38. 38. Johnson DE, Alderman EL, Schroeder JS, et al: Transplant coronary artery disease: Histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991;17:449-457.
39. 39. Lim TT, Liang DH, Botas J, et al: Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study. Circulation 1997;95:855-859.
40. 40. Wener LS, Johnson JA, Tobis JM, et al: Longitudinal study of vascular remodeling in coronary arteries after heart transplantation. (Abstract) Circulation 1997;96:1-429.
41. 41. Austin GE, Ratliff NB, Hollman J, et al. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-375.
42. 42. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 1991;17:433-439.
43. 43. Waller BF, Pinkerton CA, Orr CM, et al. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty. Circulation 1991;83:128-41.
44. 44. Pickering JG, Weir L, Jekanowski J, et al. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993;91:1469-1480.
45. 45. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation 1996;94:35-43.
46. 46. Lansky AJ, Mintz GS, Popma JJ, et al. Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): A serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study. J Am Coll Cardiol 1998;32;329-337.
47. 47. Kimura T, Kaburagi S, Tamura T, et al. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 1997;96:475-483.
48. 48. Hoffmann R, Mintz GS, Popma JJ, et al. Chronic arterial responses to stent implantation: A serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol 1996;28:1134-1139.
49. 49. Mintz GS, Popma JJ, Hong MK, et al: Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol 1996;78:18-22.
50. 50. Tardif JC, Cote G, Lesperance J, et al: Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 1997;337:365-372.
51. 51. Yokoi H, Daida H, Kuwabara Y, et al: Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol 1997;30:855-862.
52. 52. Watanabe K, Sekiya M, Ikeda S, et al: Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1996;132:23-29.
53. 53. Setsuda M, Inden M, Hiraoka N, et al: Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty. Clin Ther 1993;15:374-382.
54. 54. King SB, Williams DO, Chougule P, et al: Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: Results of the Beta Energy Restenosis Trial (BERT). Circulation 1998;97:2025-2030.
55. 55. Maresta A, Balducelli M, Cantini L, et al. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation 1994;90:2710-2715.
56. 56. Okamoto S, Inden M, Setsuda M, et al: Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1992;123:1439-1444.
57. 57. Cote G, Tardif JC, Lesperance J, et al: Effects of probucol on vascular remodeling after coronary angioplasty. Circulation 1999;99:30-35.
58. 58. Waksman R, Rodriguez JC, Robinson KA, et al: Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997;96:1944-1952.
59. 59. Fukumoto Y, Shimokawa H, Kozai T, et al: Tyrosine kinase inhibitor suppresses the (re) stenotic changes of the coronary artery after balloon injury in pigs. Cardiovasc Res 1996;32:1131-1140.
60. 60. Knox JB, Sukhova GK, Whittemore AD, et al: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-212.
61. 61. Tamarina NA, McMillan WD, Shively VP, et al: Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997;122:264-271.
62. 62. Elmore JR, Keister BF, Franklin DP, et al: Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 1998;12:221-228.
63. 63. McMillan WD, Tamarina NA, Cipollone M, et al: Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 1997;96:2228-2232.
64. 64. Todor DR, Lewis I, Bruno G, et al: Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 1998;29;1580-1583.
65. 65. Nikkari ST, Hoyhtya M, Isola J, et al: Macrophages contain 92-kD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996;149:1427-1433.
66. 66. Thompson MM, Wills A, McDermott E, et al. An in vitro model of aneurysmal disease: Effect of leukocyte infiltration and shear stress on MMP production within the arterial wall. Ann N Y Acad Sci 1996;800:270-273.
67. 67. Freestone T, Turner RJ, Higman DJ, et al: Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arterioscler Thromb Vasc Biol 1997;17:10-17.
68. 68. Zaltsman AB, Newby AC: Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: Relationship to lesion severity. Atherosclerosis 1997;130:61-70.
69. 69. Galis ZS, Asanuma K, Godin D, et al. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: New target for antioxidant therapy. Circulation 1998;97:2445-2453.
70. 70. Petrinec D, Liao S, Holmes DR, et al: Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996;23:336-346.
71. 71. Holmes DR, Petrinec D, Wester W, et al: Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res 1996;63:305-309.
72. 72. Boyle JR, McDermott E, Crowther M, et al: Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg 1998;27:354-361.
73. 73. Allaire E, Hasenstab D, Kenagy RD, et al: Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-J. Circulation 1998;98:249-255.